How has been the historical performance of Mercury Labs?

Nov 12 2025 11:48 PM IST
share
Share Via
Mercury Labs has experienced mixed financial performance, with net sales peaking at 75.56 Cr in Mar'24 but declining to 75.10 Cr in Mar'25, alongside a drop in profit after tax from 5.65 Cr to 3.14 Cr. Despite an increase in total assets, profitability and cash flow have decreased, indicating operational challenges.
Answer:
The historical performance of Mercury Labs shows a mixed trend in key financial metrics over the past several years.

Breakdown:
Mercury Labs' net sales have seen slight fluctuations, with a peak of 75.56 Cr in Mar'24 and a decrease to 75.10 Cr in Mar'25, compared to 75.33 Cr in Mar'23. Total operating income followed a similar pattern, reaching 75.56 Cr in Mar'24 before dropping to 75.10 Cr in Mar'25. The company's total expenditure (excluding depreciation) increased from 66.52 Cr in Mar'24 to 68.08 Cr in Mar'25, impacting the operating profit, which fell from 9.04 Cr in Mar'24 to 7.02 Cr in Mar'25. Consequently, profit before tax also declined from 6.92 Cr in Mar'24 to 4.66 Cr in Mar'25, leading to a profit after tax of 3.14 Cr in Mar'25, down from 5.65 Cr in Mar'24. The earnings per share (EPS) decreased significantly from 47.08 in Mar'24 to 26.17 in Mar'25. On the balance sheet, total assets rose from 67.96 Cr in Mar'24 to 74.24 Cr in Mar'25, while total liabilities increased from 67.96 Cr to 74.24 Cr in the same period. The cash flow from operating activities decreased from 8.00 Cr in Mar'24 to 4.00 Cr in Mar'25, contributing to a net cash outflow of 6.00 Cr in Mar'25, compared to no net cash flow in Mar'24. Overall, while Mercury Labs has shown growth in total assets, the decline in profitability and cash flow indicates challenges in maintaining operational efficiency.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Mercury Laboratories Ltd is Rated Sell
Jan 15 2026 10:10 AM IST
share
Share Via
Why is Mercury Laboratories Ltd falling/rising?
Jan 15 2026 12:46 AM IST
share
Share Via
Mercury Laboratories Ltd is Rated Sell
Jan 04 2026 10:10 AM IST
share
Share Via
Mercury Laboratories Ltd is Rated Sell
Dec 24 2025 08:23 PM IST
share
Share Via
How has been the historical performance of Mercury Labs?
Dec 02 2025 10:57 PM IST
share
Share Via
Are Mercury Labs latest results good or bad?
Nov 13 2025 07:33 PM IST
share
Share Via